Trade Mark Journal No.2026/044 30 October 2026
WO0000001942641 (5,42)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:20 August 2026
Date of designation in the UK:
20 August 2026
International priority date claimed: 25 February 2026
(European Union Intellectual Property Office (EUIPO))
(019321890)
- Class 5
- Diagnostic biomarker reagents for medical purposes; diagnostic reagents for biomarkers for veterinary use; cord blood for medical purposes; umbilical cords for clinical use; placentas for medicinal use; placentas for clinical use; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; diagnostic kits consisting of medical and veterinary diagnostic reagents and assays for use in connection with disease tracing, disease analysis and the quantification of disease activity; diagnostic agents for medical use; diagnostic reagents for medical use; clinical diagnostic agents; diagnostics for veterinary purposes; diagnostic reagents for veterinary use; diagnostic agents for veterinary use; clinical diagnostic reagents; diagnostic agents and diagnostic materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic preparations for medical or veterinary purposes.
- Class 42
- Design and development of the following goods: blood-based biomarkers for the identification, quantification and analysis of disease activity; design and development of the following goods: diagnostic biomarker reagents for medical, veterinary and pharmaceutical purposes and for scientific purposes; design and development of the following goods: biochemical and pharmaceutical assays and medical samples; design and development of the following goods: biomarkers for individual use or combined for the tracking of tissue formation, development or tissue degradation; pharmaceutical and scientific research relating to the following fields: biomarkers and the detection of biomarkers; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to the following fields: clinical trials; veterinary trials; medical experiments; analysis of pharmacodynamic data; analysis of data in connection with the following fields: biomarkers; development of the following goods: diagnostic preparations for medical and veterinary purposes; diagnostic equipment and diagnostic tests; clinical testing services; diagnostic testing services; testing services relating to the following fields: tracking and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratories; medical, pre-clinical, clinical, biological, biotechnological, veterinary and pharmaceutical research, the conducting of experiments, development and analysis; information, advice and assistance relating to the aforementioned services.
Nordic Bioscience A/S
Representative: CHAS. HUDE A/S, Bredgade 20, 3., DK-1260 København K, DENMARK